Inactive Instrument

All News ICON PLC Irish S.E.

Equities

ICON Public : plc 2023 IFRS Annual Report	06-10	PU
ICON Public : plc 2024 AGM Notice and Proxy Materials	06-10	PU
ICON Public : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION Form 6 K	06-10	PU
Transcript : ICON Public Limited Company Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 01:30 PM	06-06
ICON plc to Present at the Jefferies Global Healthcare Conference	06-04	BU
Baird Adjusts Price Target on ICON to $367 From $363, Maintains Outperform Rating	05-31	MT
Transcript : ICON Public Limited Company - Analyst/Investor Day	05-30
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance	05-30	BU
ICON Public Limited Company Reaffirms Earnings Guidance for the Year 2024	05-30	CI
ICON plc to hold Investor Day Meeting on May 30, 2024	05-20	BU
Diamyd Medical AB Appoints ICON plc to Conduct Interim Analysis for the Phase 3 Trial	05-16	CI
ICON releases its ICON Cares 2023 Report	05-09	BU
ICON Public : Underwriting Agreement - Form 6-K	05-08	PU
ICON Prices $2 Billion Debt Offering	04-30	MT
ICON Announces Pricing of USD 2 Billion Notes	04-30	BU
ICON Public Limited Company Announces Pricing of USD 2 Billion Notes	04-30	CI
UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating	04-26	MT
ICON Seeks M&A	04-25	CI
Transcript : ICON Public Limited Company, Q1 2024 Earnings Call, Apr 25, 2024	04-25
ICON Q1 Adjusted EPS, Revenue Rise, 2024 Guidance Range Narrowed	04-24	MT

No results for this search